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partner) decisions about HCT. The margin of error was set
at 5% and degree of conﬁdence 95%.
Results: Acceptance of HIV testing among the inter-
viewed pregnant women was 74.5%. Stigma and discrimina-
tion by the community, husband reaction and fear of positive
test result were reasons that impede higher acceptance
of HIV testing. Acceptance of HIV testing was signiﬁcantly
associated with pregnant women who had attended formal
education, reside in urban area, living with their partners
and those mentioned ART as PMTCT. Only 27% of pregnant
women could decide independently on accepting HIV test-
ing. Male partners, who came to health centers along with
their partners for ANC and HIV testing, were only 5.1%. Two
third of the study participants (65.5%) have no habit of open
discussion on HIV/STI with their male partners. Most women
with positive test result do not disclose their test result to
their partners. Pregnant women who could get partner sup-
port with positive test result were more likely to accept HIV
testing than their counterparts.
Conclusion: HIV testing acceptance is encouraging but
men’s involvement was found to be low and they appear
to be the secrete ingredient of PMTCT intervention. Gen-
erally, pregnant women need their male partners’ positive
attitude and support to accept HIV testing. Hence PMTCT
programs should give emphasis on involvement of male
partners.
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Attitudes towards neonatal male circumcision among His-
panic men and women in Miami, Florida
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Background: Hispanics in the U.S. with the lowest rates
of circumcision (MC) and relatively higher rates of hetero-
sexual HIV transmission may beneﬁt with higher rates of MC.
Before interventions to promote MC can be introduced in the
Hispanic community, additional information is necessary to
determine the factors that are related to its acceptability
in this population.
Methods: We conducted a qualitative study to assess the
attitudes towards neonatal MC in Hispanic pregnant females
and males and intensive interviews with 12 providers of the
Hispanic community. Gender concordant focus groups were
held to address the relative acceptability of MC. Each focus
group (2 male, 4 female) was lead by 2 trained facilita-
tors (medical, psychosocial). Key informants of the Hispanic
community had an individualized indepth structured inter-
views.
Results: Qualitative data was analyzed for dominant
themes and collapsed into overarching themes. Thirteen
themes emerged, including acceptability, appearance, cir-
cumcision and children, circumcision and HIV, cost, cultural
differences, health beneﬁts, knowledge and personal expe-
riences, pain and injury to the penis, perceived HIV risk,
religion, sexual performance and sexual pleasure. Men
associated acceptability with the attitudes of health care
professionals, knowledge about the procedure and hygiene.
-
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omen focused on cost, cultural differences, circumcised
amily members and decision making for circumcising chil-
ren. Attitudes regarding MC differed between national/
ultural group and gender; excepting the Mohel, Hispanic
ale providers related MC acceptability to American Pedi-
tric Association guidelines, personal circumcision status
nd were skeptical regarding its health beneﬁts for STD/HIV
isk reduction. Female providers focused on the ﬁnancial
urden to parents in its provision to neonates, lack of
nformation and the need to increase acceptability among
ispanic men.
Conclusion: Both women and men appeared accepting
f neonatal circumcision, and the women were assertive
egarding their role as decision makers regarding the pro-
edure.
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atients with newly-diagnosed HIV in 2004 versus 2008:
o apparent difference in progression
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Background: Trends have recently been observed suggest-
ng more rapid progression in newly-diagnosed HIV-positive
atients. This data is limited by an inability to speciﬁ-
ally identify the time of infection. Our HIV-positive cohort
isplays heterogenous acquisition risk and signiﬁcant immi-
ration from countries of high prevalence, and is ideal to
tudy changing epidemiology.
Methods: A retrospective cohort study was undertaken
omparing newly diagnosed HIV patients attending in the
rst half of 2004 with those in 2008. Baseline demograph-
cs and virological parameters were gathered. Progression
as followed for the ﬁrst year after diagnosis. Patients
ith known seroconversion were of particular interest —
ncluding those certain of time of infection, who recalled sig-
iﬁcant seroconversion illness and/or a negative test within
he preceding 6 months. Others with previous negative tests
utside this window were not designated as known serocon-
erters. Rapid progressors (RPs) were deﬁned as those with
ocumented seroconversion window< 2 years prior to pre-
entation, who progressed to CD4 ≤350 cells/mm3 within
rst year of follow-up. Results were analysed using Graph-
adInStat.
Results: Of the 200 charts reviewed, 96 met inclusion
riteria. Baseline characteristics are summarized in Table 1.
D4 ≤350 cellls/mm3 at ﬁrst presentation in 2004 and 2008
espectively was seen in 20(48%) and 31(57%) p = 0.42. CD4
ount ≤350 by end of year 1 was 25(60%) vs 35(65%) p = 0.67.
ean change in CD4% from diagnosis to end of year 1 or pre-
RT was -2.9%(SD5.1) vs +7.2%(SD 11.0) p < 0.0001 (95%CI,
13.7718 to -6.4882). AIDS-deﬁning illness in ﬁrst year was
een in 6(14%) vs 7(13%) p = 1.0. Of those with CD4 ≥350
ells/mm3 at ﬁrst presentation, 18 (82%) vs 18 (78%) main-
ained CD4 ≥350 at end of year 1 untreated. Of those with
